2 xingyaboshoujiapp（t2dm）youyaboshoujiappqianqifazhanerlai。 yaboshoujiappqianqikeyibeirenweishiyizhongbiaozhihuofenshuiling，tadechuxianbiaozhizhejianglaifashengnaoxinxueguanbing（cerebro cardiovascular disease，ccvd）､yaboshoujiapp､weixueguanbingyijizhongliuhechidaidengdeweixianxingzenggao。xianyoudeyanjiuyizhengmingyouxiaoganyuyaboshoujiappqianqikemingxianjianshaoqizhuanhuaweiyaboshoujiapp。yinci，jishifaxianxuetangzhengchangxingyaboshoujiappgaoweirenqunheyaboshoujiappqianqirenqunbingjinxingyouxiaoguanlishiyufangyaboshoujiappfashengdeguanjian。
2008年中华医学会亚博手机app学分会（CDS）组织的中国14省亚博手机app流行病学调查结果显示，在 20 岁以上的人群中，年龄标化的亚博手机app患病率为9.7%，患病人数达 9240 万例，居全球之首；而亚博手机app前期的患病率高达15.5%，人数在14800万以上。
亚博手机app调查发现，男性亚博手机app前期患病率为16.1%，其中空腹血糖受损（Impaired Fasting Glucose/glycemia，IFG）､糖耐量减低（Impaired Glucose Tolerance，IGT）与IFG 合并IGT分别为 3.2%､11.0% 和 1.9%；女性亚博手机app前期患病率为 14.8%，IFG､IGT 和 IFG 合并 IGT 分别为2.2%､10.9%与 1.7%。
zhenduanweiyaboshoujiappqianqiderenqunzhong，nanxingifg zhan 19.9%，igt zhan 68.3%，ifg+igt zhan11.08%；nvxingifg zhan 14.9%，igt zhan 73.6%，ifg+igt zhan 11.5%。2010 nianwanchengdewoguo 18 suiyishangchengrenliuxingbingxuediaocha，gusuandeyaboshoujiappqianqihuanbinglvwei50.1%。zheilianggedaxingyanjiushuomingwoguoyaboshoujiappqianqihuanbinglvgaoqieyicanhougaoxuetangweizhu。ciwai，youyuyaboshoujiappqianqiyiban wulinchuangbiaoxian，qishouzhongshichengduyuanyuanbugou。jianyuci，zhonghuayixuehuineifenmixuefenhuiyu 2013nianzhidinglezhongguochengren 2 xingyaboshoujiappyufangdezhuanjiagongshi。
1 gongshizhuyaoneirong
亚博手机app1.1 zhengjudengji canzhaowenxianmeiguoyaboshoujiappxuehui（ada）dezhengjudengjifenjibiaozhun，biaozhuyuxiangyingzhengjuhoudekuohaozhong。
亚博手机app1.2 yaboshoujiappgaoweirenqundingyi yaboshoujiappgaoweirenqunbaokuoxuetangzhengchangxinggaoweirenqunheyaboshoujiappqianqirenqun。
1.2.1 xuetangzhengchangxinggaoweirenqun chengnianren（>18 sui）juyouxialierenheyigejiyishangdeyaboshoujiappgaoweiyinsu，kedingyiweiyaboshoujiappgaoweirenqun:（1）nianling≥40 sui；（2）jiwangyouyaboshoujiappqianqibingshi；（3）chaozhong､feipang[tizhizhishu（bmi）≥24）]，nanxingyaowei≥90cm，nvxingyaowei≥85cm；（4）jingzuodeshenghuofangshi； （5）yijiqinshuzhongyou 2xingyaboshoujiappjiazushi；（6）youjudaer（chushengtizhong≥4kg）shengchanshi，huorenshenqixianxingyaboshoujiapphuorenshenyaboshoujiapp（gdm）shidefunv；（7）gaoxueya[shousuoya ≥140mmhg he（huo）shuzhangya≥90mmhg]，huozhengzaijieshoujiangyazhiliao；（8）xuezhiyichang[gaomiduzhidanbaidanguchun（hdl-c）≤0.91mmol/l jisanxianganyou（tg）≥2.22mmol/l，huozhengzaijieshoudiaozhizhiliao]；（9）dongmaizhouyangyinghuaxingccvd huanzhe；（10）youyiguoxingleiguchunxingyaboshoujiappbingshizhe；（11）duonangluanchaozonghezheng（pcos）huanzhe；（12）yanzhongjingshenbinghe（huo）zhangqijieshoukangyiyuzhengyaowuzhiliaodehuanzhe。
1.2.2 亚博手机app前期人群 亚博手机app前期指空腹血浆葡萄糖（FPG）或（和）口服葡萄糖耐量试验（OGTT）2 h 血浆葡萄糖（2hPG）升高但未达到亚博app下载的诊断标准，即存在IFG 或IGT 或两者兼具（IFG + IGT）。 亚博手机app前期的诊断标准见表 1。本文除特别注明外，亚博手机app前期的诊断即同表 1。
1.3 亚博手机app高危人群的筛查
亚博手机appwuyaboshoujiappbingshizhe，shouxiangenjugaoweiyinsu（tongshang）jinxingchushai，duiyujuyouyixiangweixianyinsuzhejinyibujinxing fpg huorenyidianxuetang（rpg）shaicha。（1）fpg:jianyiyi fpg≥5 6 mmol/ l zuoweixingkoufuputaotangnailiangshiyan（ogtt）deqiedian。（2）rpg:jianyiyi rpg≥7.8 mmol/ l zuoweixing ogtt deqiedian。（3）youyu fpg<5.6 mmol/ l huo rpg <7.8 mmol/ l derenquntebieshilaonianrenqunbunengwanquanpaichuigt jicanhouxuetangshenggaodeyaboshoujiapp，yincilaonianjiqitagaoweizhe（quezhenguanxinbinghuohebingjiaoduoweixianyinsu）yejianyixing ogtt mingquexuetangdaixiedeqingkuang。
亚博手机app1.4 yaboshoujiappgaoweirenqundeguanli
亚博手机app1.4.1 xuetangzhengchangxingyaboshoujiappgaoweirenqundeguanli
亚博手机app（1）jiankangjiaoyu:muqianquefazhengjuyugongshi。cankaoyaboshoujiappjiankangjiaoyu，jianyimeiweigaoweizhehe（huo）jiashu（zhaohuzhe）yingjieshouxitongxingdejiaoyu，bingqiezuodaomeiniangongguyici。jiaoyudeneirong zhishaoyingbaokuoyaboshoujiappqianqijiyaboshoujiappxiangguanzhishi，rushenmeshiyaboshoujiappqianqijiyaboshoujiapp､yixueyingyangzhiliao､yundonghejieyandejibenzhishideng；ciwaihaiyingbaokuogairenqundeqitaccvd fengxiandeguanlizhishi。
（2）其他干预:①生活方式干预。这是干预的基础。应建议通过医学营养治疗和运动等强化生活方式干预减少发生亚博app下载的风险。推荐肥胖或超重者控制至正常 BMI < 24，或体重至少减少 5% ~ 10%；每日饮食总热量至少减少1680 ~2100 kJ；饱和脂肪酸摄入占总脂肪酸摄入的30%以下；体力活动时间增加到 250 ~ 300 min/周。 开始生活方式干预后，须定期随访其执行度。②其他CCVD风险的管理，如血压､血脂同等重要，详细指标见控制目标部分。
（3）监测:开始生活方式干预后，须定期随访该人群的血糖变化情况，建议每年至少一次于医院行 FPG 和（或）OGTT 检查。
1.4.2 yaboshoujiappqianqirenqundeguanli
